{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:14Z","timestamp":1791489674826,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":230,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101390","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:50:48Z","timestamp":1787971848000},"page":"101390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An immune-metabolic transcriptomic balance stratifies acute myeloid leukemia and reveals distinct immunological and signaling dependencies"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1940-1610","authenticated-orcid":false,"given":"Saida","family":"Rahmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdessamad","family":"Hachmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajae","family":"Taibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Bouhtit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noureddine","family":"Boukhatem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fayyad-Kazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelilah","family":"Berhili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Seddik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Fayyad-Kazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makram","family":"Merimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ctarc.2026.101390_bib0001","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/ajh.26309","article-title":"A novel 4-mRNA signature predicts the overall survival in acute myeloid leukemia","volume":"96","author":"Chen","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101390_bib0002","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41375-023-01884-2","article-title":"Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia","volume":"37","author":"Rausch","year":"2023","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0003","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41467-022-35624-4","article-title":"Early response evaluation by single cell signaling profiling in acute myeloid leukemia","volume":"14","author":"Tislevoll","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0004","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41467-022-32103-8","article-title":"Unified classification and risk-stratification in acute myeloid leukemia","volume":"13","author":"Tazi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101390_bib0005","article-title":"Construction of a solid cox model for AML patients based on multiomics bioinformatic analysis","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0006","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.1038\/s41598-024-58860-8","article-title":"Ablation of Wnt signaling in bone marrow stromal cells overcomes microenvironment-mediated drug resistance in acute myeloid leukemia","volume":"14","author":"Palani","year":"2024","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101390_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112833","article-title":"A role for the bone marrow microenvironment in drug resistance of acute myeloid leukemia","volume":"10","author":"Bolandi","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0008","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41420-022-01193-0","article-title":"The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: from biology to therapeutic targeting","volume":"8","author":"Chen","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ctarc.2026.101390_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1192333","article-title":"Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche","volume":"14","author":"Alberti","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","article-title":"Catch me if you can: how AML and its niche escape immunotherapy","volume":"36","author":"Tettamanti","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.ctarc.2026.101390_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.811144","article-title":"Tumor microenvironment in acute myeloid leukemia: adjusting niches","volume":"13","author":"Menter","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101390_bib0012","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10456-024-09913-z","article-title":"Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism","volume":"27","author":"Yang","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ctarc.2026.101390_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1384721","article-title":"Aberrant tumor vasculature. Facts and pitfalls","volume":"15","author":"Ribatti","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101390_bib0014","article-title":"VEGF signaling: role in angiogenesis and beyond","volume":"1879","author":"Shaw","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0015","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41467-024-45691-4","article-title":"Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth","volume":"15","author":"Kellaway","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0016","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12964-023-01282-2","article-title":"The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways","volume":"21","author":"Bakhtiyari","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0017","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00277-022-05025-0","article-title":"A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy","volume":"102","author":"Berdel","year":"2023","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101390_bib0018","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11010-024-05010-3","article-title":"Ang-1 and VEGF: central regulators of angiogenesis","volume":"480","author":"Zhao","year":"2025","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101390_bib0019","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","article-title":"Targeting angiogenesis in oncology, ophthalmology and beyond","volume":"22","author":"Cao","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ctarc.2026.101390_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1163786","article-title":"Weaving the nest: extracellular matrix roles in pre-metastatic niche formation","volume":"13","author":"Patras","year":"2023","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101390_bib0021","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12079-023-00722-5","article-title":"Why do humans need thrombospondin-1?","volume":"17","author":"Kaur","year":"2023","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.ctarc.2026.101390_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.898772","article-title":"Thrombospondin-1 signaling through the calreticulin\/LDL receptor related protein 1 axis: functions and possible roles in glaucoma","volume":"10","author":"Murphy-Ullrich","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0023","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1038\/s41467-023-41095-y","article-title":"THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer","volume":"14","author":"Omatsu","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0024","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41698-024-00523-y","article-title":"INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer","volume":"8","author":"Hu","year":"2024","journal-title":"NPJ Precis. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101390_bib0025","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10555-024-10186-7","article-title":"Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy","volume":"43","author":"Guo","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ctarc.2026.101390_bib0026","article-title":"High thrombospondin 1 expression is associated with aging and poor prognosis in patients with acute myeloid leukemia","author":"Chen","year":"2023","journal-title":"Res. Sq."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0027","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41467-023-36824-2","article-title":"LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1","volume":"14","author":"vom Stein","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101390_bib0028","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12987-026-00774-w","article-title":"Compartmentalized VEGF receptor expression in hypothalamic tanycytes reveals a novel non-endothelial axis of VEGF signaling","volume":"23","author":"Desruelle","year":"2026","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101390_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284131","article-title":"VEGF-A165 is the predominant VEGF-A isoform in platelets, while VEGF-A121 is abundant in serum and plasma from healthy individuals","volume":"18","author":"Yamakuchi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ctarc.2026.101390_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1199354","article-title":"Editorial: acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment","volume":"13","author":"Dancik","year":"2023","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101390_bib51","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"Bottomly","year":"2022","journal-title":"Cancer Cell"},{"issue":"23","key":"10.1016\/j.ctarc.2026.101390_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314543","article-title":"Role of biomarkers in the management of acute myeloid leukemia","volume":"23","author":"Small","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101390_bib0032","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1158\/2643-3230.BCD-23-0125","article-title":"The inflamed niche: a double-edged sword in AML?","volume":"4","author":"Lisi-Vega","year":"2023","journal-title":"Blood Cancer Discov."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0033","article-title":"High STAT4 expression correlates with poor prognosis in acute myeloid leukemia and facilitates disease progression by upregulating VEGFA expression","volume":"19","author":"Li","year":"2024","journal-title":"Open Med (Wars)"},{"key":"10.1016\/j.ctarc.2026.101390_bib0034","doi-asserted-by":"crossref","DOI":"10.1515\/med-2023-0840","article-title":"High STAT4 expression correlates with poor prognosis in acute myeloid leukemia and facilitates disease progression by upregulating VEGFA expression","volume":"19","author":"Li","year":"2024","journal-title":"Open Med."},{"key":"10.1016\/j.ctarc.2026.101390_bib0035","doi-asserted-by":"crossref","DOI":"10.1166\/jbmb.2024.2468","article-title":"Inhibition of acute myeloid leukaemia development by bittersweet based on miR-let-7a regulating vascular endothelial growth factor A resistance mechanism","author":"Guo","year":"2024","journal-title":"J. Biobased Mater. Bioenergy"},{"key":"10.1016\/j.ctarc.2026.101390_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01567","article-title":"THBS1 is a novel serum prognostic factors of acute myeloid leukemia","volume":"9","author":"Zhu","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0037","article-title":"Construction of a prognostic risk model for acute myeloid leukemia based on exosomal genes and analysis of immune microenvironment characteristics","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101390_bib0038","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiaf065","article-title":"Hypoxia-activated CBS\/H2S signaling drives drug resistance in AML through CD36-mediated fatty acid metabolism","author":"Li","year":"2025","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ctarc.2026.101390_bib0039","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1182\/blood.V126.23.2595.2595","article-title":"Genetic profile and novel thrombospondin-1(THBS1) mutation of familial AML syndrome: a genomic analysis by whole genome sequencing and whole transcriptome sequencing","volume":"126","author":"Kim","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13059-024-03401-9","article-title":"Assessing and mitigating batch effects in large-scale omics studies","volume":"25","author":"Yu","year":"2024","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0041","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s43556-025-00263-w","article-title":"Applications of gene pair methods in clinical research: advancing precision medicine","volume":"6","author":"Wu","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.ctarc.2026.101390_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.764698","article-title":"The bone marrow microenvironment mechanisms in acute myeloid leukemia","volume":"9","author":"Pimenta","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"21","key":"10.1016\/j.ctarc.2026.101390_bib0043","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.3390\/cancers13215319","article-title":"Emerging bone marrow microenvironment-driven mechanisms of drug resistance in acute myeloid leukemia: tangle or chance?","volume":"13","author":"Ciciarello","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0044","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12915-024-01856-7","article-title":"The fitness trade-off between growth and stress resistance determines the phenotypic landscape","volume":"22","author":"Kim","year":"2024","journal-title":"BMC Biol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101390_bib0045","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/bjh.19314","article-title":"Venetoclax resistance in acute myeloid leukaemia\u2014clinical and biological insights","volume":"204","author":"Nachmias","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101390_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091586","article-title":"Unraveling venetoclax resistance: navigating the future of HMA\/venetoclax-refractory AML in the molecular era","volume":"17","author":"Chatzilygeroudi","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101390_bib0047","article-title":"A CD8(+) T cell related immune score predicts survival and refines the risk assessment in acute myeloid leukemia","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101390_bib0048","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-cancerbio-062822-025055","article-title":"Mechanisms of resistance to targeted therapies in AML","volume":"8","author":"Jones","year":"2024","journal-title":"Annu. Rev. Cancer Biol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101390_bib0049","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/cancers17010135","article-title":"A novel in vitro model of the bone marrow microenvironment in acute myeloid leukemia identifies CD44 and focal adhesion kinase as therapeutic targets to reverse cell adhesion-mediated drug resistance","volume":"17","author":"Ladikou","year":"2025","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101390_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/biom15050716","article-title":"CXCR family and hematologic malignancies in the bone marrow microenvironment","volume":"15","author":"Liu","year":"2025","journal-title":"Biomolecules"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:41:42Z","timestamp":1791488502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":51,"alternative-id":["S2468294226003011"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101390","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An immune-metabolic transcriptomic balance stratifies acute myeloid leukemia and reveals distinct immunological and signaling dependencies","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101390"}}